Evaluation of the Efficacy and Safety of Zeprumetostat in Relapsed/Refractory Large Granular Lymphocyte Leukemia (T-LGLL)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Clinical Study on the Efficacy and Safety of Zeprumetostat in Relapsed/Refractory Large Granular Lymphocyte Leukemia (NCT07692529) | Institute of Hematology & Blood Diseases Hospital, China | 2026-08-30 |
Track Evaluation of the Efficacy and Safety of Zeprumetostat in Relapsed/Refractory Large Granular Lymphocyte Leukemia (T-LGLL) automatically
Every clearance here is in the API, with alerts when new ones post.